Suwon-si, South Korea

Kyung-Bock Lee


Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Sacheon-si, KR (2008)
  • Suwon-si, KR (2009)

Company Filing History:

goldMedal2 out of 4 
 
Fcb-pharmicell Co., Ltd.
 patents
silverMedal1 out of 4 
 
Lifecord Inc., Corp.
 patents
bronzeMedal2 out of 832,891 
Other
 patents
where one patent can have more than one assignee

Years Active: 2008-2009

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Kyung-Bock Lee

Introduction

Kyung-Bock Lee is a notable inventor based in Suwon-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in stem cell research. With a total of 2 patents, his work focuses on methods for differentiating stem cells into neural cells, which has implications for treating neurodegenerative diseases.

Latest Patents

One of his latest patents is a method for differentiating mesenchymal stem cells into neural cells. This innovative approach involves culturing mesenchymal stem cells in a medium that contains epidermal growth factor and hepatocyte growth factor. This method enhances the efficiency and maturity of the differentiated neural cells compared to conventional techniques. Another patent involves producing lymphoid dendritic cells with the immunophenotype CD8α. This is achieved by culturing human hematopoietic stem cells in a medium containing GM-CSF, followed by a medium containing IFN-α5. These lymphoid dendritic cells have potential applications in various immunotherapies.

Career Highlights

Kyung-Bock Lee has worked with Fcb-Pharmicell Co., Ltd., where he has contributed to advancements in stem cell technology. His research has been pivotal in developing new therapeutic strategies for neurodegenerative diseases.

Collaborations

He has collaborated with notable colleagues, including Hyun-Soo Kim and Young-Mo Kang, who have supported his research endeavors.

Conclusion

Kyung-Bock Lee's innovative work in stem cell differentiation and immunotherapy positions him as a key figure in biotechnology. His patents reflect a commitment to advancing medical science and improving treatment options for patients with neurodegenerative diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…